{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:49:30Z","timestamp":1777477770228,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T00:00:00Z","timestamp":1475539200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00259-016-3517-z","type":"journal-article","created":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T22:05:39Z","timestamp":1475532339000},"page":"296-307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [18F]PBR102 and [18F]PBR111"],"prefix":"10.1007","volume":"44","author":[{"given":"S.","family":"Eberl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Katsifis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Peyronneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Loc\u2019h","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Greguric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Verschuer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Mattner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Fulham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,4]]},"reference":[{"key":"3517_CR1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/jnr.490380402","volume":"38","author":"J Bauer","year":"1994","unstructured":"Bauer J, Sminia T, Wouterlood FG, Dijkstra CD. Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis. J Neurosci Res. 1994;38:365\u201375. doi:\n                    10.1002\/jnr.490380402\n                    \n                  .","journal-title":"J Neurosci Res"},{"key":"3517_CR2","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.pneurobio.2006.10.002","volume":"80","author":"S Venneti","year":"2006","unstructured":"Venneti S, Lopresti BJ, Wiley CA. The peripheral benzodiazepine receptor (translocator protein 18 kDa) in microglia: from pathology to imaging. Prog Neurobiol. 2006;80:308\u201322.","journal-title":"Prog Neurobiol"},{"key":"3517_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/(SICI)1097-4547(19971015)50:2<345::AID-JNR22>3.0.CO;2-5","volume":"50","author":"E Vowinckel","year":"1997","unstructured":"Vowinckel E, Reutens D, Becher B, Verge G, Evans A, Owens T, et al. PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurosci Res. 1997;50:345\u201353.","journal-title":"J Neurosci Res"},{"key":"3517_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.parkreldis.2012.07.002","volume":"19","author":"S Iannaccone","year":"2013","unstructured":"Iannaccone S, Cerami C, Alessio M, Garibotto V, Panzacchi A, Olivieri S, et al. In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson\u2019s disease. Parkinsonism Relat Disord. 2013;19:47\u201352. doi:\n                    10.1016\/j.parkreldis.2012.07.002\n                    \n                  .","journal-title":"Parkinsonism Relat Disord"},{"key":"3517_CR5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ana.20338","volume":"57","author":"Y Ouchi","year":"2005","unstructured":"Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, et al. Microglial activation and dopamine terminal loss in early Parkinson\u2019s disease. Ann Neurol. 2005;57:168\u201375. doi:\n                    10.1002\/ana.20338\n                    \n                  .","journal-title":"Ann Neurol"},{"key":"3517_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/00002093-198802040-00001","volume":"2","author":"EG McGeer","year":"1988","unstructured":"McGeer EG, Singh EA, McGeer PL. Peripheral-type benzodiazepine binding in Alzheimer disease. Alzheimer Dis Assoc Disord. 1988;2:331\u20136.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"3517_CR7","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1080\/13550280500187351","volume":"11","author":"DA Hammoud","year":"2005","unstructured":"Hammoud DA, Endres CJ, Chander AR, Guilarte TR, Wong DF, Sacktor NC, et al. Imaging glial cell activation with [C-11]-R-PK11195 in patients with aids. J Neurovirol. 2005;11:346\u201355.","journal-title":"J Neurovirol"},{"key":"3517_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0304-3940(97)00967-1","volume":"241","author":"K Messmer","year":"1998","unstructured":"Messmer K, Reynolds GP. Increased peripheral benzodiazepine binding sites in the brain of patients with Huntington\u2019s disease. Neurosci Lett. 1998;241:53\u20136.","journal-title":"Neurosci Lett"},{"key":"3517_CR9","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1212\/WNL.55.7.1052","volume":"55","author":"S Pappata","year":"2000","unstructured":"Pappata S, Levasseur M, Gunn RN, Myers R, Crouzel C, Syrota A, et al. Thalamic microglial activation in ischemic stroke detected in vivo by PET and [C-11]PK11195. Neurology. 2000;55:1052\u20134.","journal-title":"Neurology"},{"key":"3517_CR10","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nn.4132","volume":"18","author":"H Asai","year":"2015","unstructured":"Asai H, Ikezu S, Tsunoda S, Medalla M, Luebke J, Haydar T, et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci. 2015;18:1584\u201393. doi:\n                    10.1038\/nn.4132\n                    \n                  .","journal-title":"Nat Neurosci"},{"key":"3517_CR11","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nrd3295","volume":"9","author":"R Rupprecht","year":"2010","unstructured":"Rupprecht R, Papadopoulos V, Rammes G, Baghai TC, Fan J, Akula N, et al. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov. 2010;9:971\u201388. doi:\n                    10.1038\/nrd3295\n                    \n                  .","journal-title":"Nat Rev Drug Discov"},{"key":"3517_CR12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.141713","author":"LE Vivash","year":"2015","unstructured":"Vivash LE, O\u2019Brien TJ. Imaging microglial activation with TSPO PET: Lighting up neurological diseases? J Nucl Med. 2015. doi:\n                    10.2967\/jnumed.114.141713\n                    \n                  .","journal-title":"J Nucl Med"},{"key":"3517_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1124\/dmd.112.046342","volume":"41","author":"MA Peyronneau","year":"2013","unstructured":"Peyronneau MA, Saba W, Goutal S, Damont A, Dolle F, Kassiou M, et al. Metabolism and quantification of [18F]DPA-714, a new TSPO positron emission tomography radioligand. Drug Metab Dispos. 2013;41:122\u201331. doi:\n                    10.1124\/dmd.112.046342\n                    \n                  .","journal-title":"Drug Metab Dispos"},{"key":"3517_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.nucmedbio.2010.07.008","volume":"38","author":"A Katsifis","year":"2011","unstructured":"Katsifis A, Loc\u2019h C, Henderson D, Bourdier T, Pham T, Greguric I, et al. A rapid solid-phase extraction method for measurement of non-metabolised peripheral benzodiazepine receptor ligands, [18F]PBR102 and [18F]PBR111, in rat and primate plasma. Nucl Med Biol. 2011;38:137\u201348. doi:\n                    10.1016\/j.nucmedbio.2010.07.008\n                    \n                  .","journal-title":"Nucl Med Biol"},{"key":"3517_CR15","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1021\/jm050155n","volume":"48","author":"AA Wilson","year":"2005","unstructured":"Wilson AA, McCormick P, Kapur S, Willeit M, Garcia A, Hussey D, et al. Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography. J Med Chem. 2005;48:4153\u201360. doi:\n                    10.1021\/jm050155n\n                    \n                  .","journal-title":"J Med Chem"},{"key":"3517_CR16","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1021\/jm7014556","volume":"51","author":"CJ Fookes","year":"2008","unstructured":"Fookes CJ, Pham TQ, Mattner F, Greguric I, Loc\u2019h C, Liu X, et al. Synthesis and biological evaluation of substituted [18F]imidazo[1,2-a]pyridines and [18F]pyrazolo[1,5-a]pyrimidines for the study of the peripheral benzodiazepine receptor using positron emission tomography. J Med Chem. 2008;51:3700\u201312.","journal-title":"J Med Chem"},{"key":"3517_CR17","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1007\/s00259-009-1353-0","volume":"37","author":"N Camp Van","year":"2010","unstructured":"Van Camp N, Boisgard R, Kuhnast B, Theze B, Viel T, Gregoire MC, et al. In vivo imaging of neuroinflammation: a comparative study between [F-18]PBR111, [C-11]CLINME and [C-11]PK11195 in an acute rodent model. Eur J Nucl Med Mol Imaging. 2010;37:962\u201372.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3517_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/jcbfm.2011.147","volume":"32","author":"DR Owen","year":"2012","unstructured":"Owen DR, Yeo AJ, Gunn RN, Song K, Wadsworth G, Lewis A, et al. An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab. 2012;32:1\u20135. doi:\n                    10.1038\/jcbfm.2011.147\n                    \n                  .","journal-title":"J Cereb Blood Flow Metab"},{"key":"3517_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2967\/jnumed.110.079459","volume":"52","author":"DR Owen","year":"2011","unstructured":"Owen DR, Gunn RN, Rabiner EA, Bennacef I, Fujita M, Kreisl WC, et al. Mixed-affinity binding in humans with 18-kDa translocator protein ligands. J Nucl Med. 2011;52:24\u201332. doi:\n                    10.2967\/jnumed.110.079459\n                    \n                  .","journal-title":"J Nucl Med"},{"key":"3517_CR20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0969-8051(00)00125-6","volume":"27","author":"J Hilton","year":"2000","unstructured":"Hilton J, Yokoi F, Dannals RF, Ravert HT, Szabo Z, Wong DF. Column-switching HPLC for the analysis of plasma in PET imaging studies. Nucl Med Biol. 2000;27:627\u201330.","journal-title":"Nucl Med Biol"},{"key":"3517_CR21","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1124\/jpet.108.143347","volume":"327","author":"HU Shetty","year":"2008","unstructured":"Shetty HU, Zoghbi SS, Simeon FG, Liow JS, Brown AK, Kannan P, et al. Radiodefluorination of 3-fluoro-5-(2-(2-[18F](fluoromethyl)-thiazol-4-yl)ethynyl)benzonitrile ([18F]SP203), a radioligand for imaging brain metabotropic glutamate subtype-5 receptors with positron emission tomography, occurs by glutathionylation in rat brain. J Pharmacol Exp Ther. 2008;327:727\u201335. doi:\n                    10.1124\/jpet.108.143347\n                    \n                  .","journal-title":"J Pharmacol Exp Ther"},{"key":"3517_CR22","first-page":"498","volume":"34","author":"T Yokoi","year":"1993","unstructured":"Yokoi T, Iida H, Itoh H, Kanno I. A new graphic plot analysis for cerebral blood flow and partition coefficient with iodine-123-iodoamphetamine and dynamic SPECT validation studies using oxygen-15-water and PET. J Nucl Med. 1993;34:498\u2013505.","journal-title":"J Nucl Med"},{"key":"3517_CR23","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1097\/00004647-199609000-00008","volume":"16","author":"J Logan","year":"1996","unstructured":"Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab. 1996;16:834\u201340. doi:\n                    10.1097\/00004647-199609000-00008\n                    \n                  .","journal-title":"J Cereb Blood Flow Metab"},{"key":"3517_CR24","first-page":"1170","volume":"20","author":"EJ Knust","year":"1979","unstructured":"Knust EJ, Kupfernagel C, Stocklin G. Long-chain F-18 fatty acids for the study of regional metabolism in heart and liver; odd-even effects of metabolism in mice. J Nucl Med. 1979;20:1170\u20135.","journal-title":"J Nucl Med"},{"key":"3517_CR25","first-page":"520","volume":"47","author":"SS Zoghbi","year":"2006","unstructured":"Zoghbi SS, Shetty HU, Ichise M, Fujita M, Imaizumi M, Liow JS, et al. PET imaging of the dopamine transporter with 18F-FECNT: a polar radiometabolite confounds brain radioligand measurements. J Nucl Med. 2006;47:520\u20137.","journal-title":"J Nucl Med"},{"key":"3517_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/(SICI)1098-1136(199709)21:1<106::AID-GLIA12>3.0.CO;2-W","volume":"21","author":"F Fonnum","year":"1997","unstructured":"Fonnum F, Johnsen A, Hassel B. Use of fluorocitrate and fluoroacetate in the study of brain metabolism. Glia. 1997;21:106\u201313.","journal-title":"Glia"},{"key":"3517_CR27","doi-asserted-by":"publisher","first-page":"982","DOI":"10.2967\/jnumed.108.057356","volume":"50","author":"J Marik","year":"2009","unstructured":"Marik J, Ogasawara A, Martin-McNulty B, Ross J, Flores JE, Gill HS, et al. PET of glial metabolism using 2-18F-fluoroacetate. J Nucl Med. 2009;50:982\u201390. doi:\n                    10.2967\/jnumed.108.057356\n                    \n                  .","journal-title":"J Nucl Med"},{"key":"3517_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.nucmedbio.2008.11.006","volume":"36","author":"T Mori","year":"2009","unstructured":"Mori T, Sun LQ, Kobayashi M, Kiyono Y, Okazawa H, Furukawa T, et al. Preparation and evaluation of ethyl [18F]fluoroacetate as a proradiotracer of [18F]fluoroacetate for the measurement of glial metabolism by PET. Nucl Med Biol. 2009;36:155\u201362. doi:\n                    10.1016\/j.nucmedbio.2008.11.006\n                    \n                  .","journal-title":"Nucl Med Biol"},{"key":"3517_CR29","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.nucmedbio.2011.09.006","volume":"39","author":"MA Peyronneau","year":"2012","unstructured":"Peyronneau MA, Saba W, Dolle F, Goutal S, Coulon C, Bottlaender M, et al. Difficulties in dopamine transporter radioligand PET analysis: the example of LBT-999 using [18F] and [11C] labelling: part II: metabolism studies. Nucl Med Biol. 2012;39:347\u201359. doi:\n                    10.1016\/j.nucmedbio.2011.09.006\n                    \n                  .","journal-title":"Nucl Med Biol"},{"key":"3517_CR30","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1021\/jm0304919","volume":"47","author":"MR Zhang","year":"2004","unstructured":"Zhang MR, Maeda J, Ogawa M, Noguchi J, Ito T, Yoshida Y, et al. Development of a new radioligand, N-(5-fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoroethyl-5-methoxybenzyl)acetamide, for PET imaging of peripheral benzodiazepine receptor in primate brain. J Med Chem. 2004;47:2228\u201335.","journal-title":"J Med Chem"},{"key":"3517_CR31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.nucmedbio.2007.12.009","volume":"35","author":"AA Wilson","year":"2008","unstructured":"Wilson AA, Garcia A, Parkes J, McCormick P, Stephenson KA, Houle S, et al. Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors. Nucl Med Biol. 2008;35:305\u201314. doi:\n                    10.1016\/j.nucmedbio.2007.12.009\n                    \n                  .","journal-title":"Nucl Med Biol"},{"key":"3517_CR32","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1021\/jm8011855","volume":"52","author":"E Briard","year":"2009","unstructured":"Briard E, Zoghbi SS, Simeon FG, Imaizumi M, Gourley JP, Shetty HU, et al. Single-step high-yield radiosynthesis and evaluation of a sensitive, F-18-labeled ligand for imaging brain peripheral benzodiazepine receptors with PET. J Med Chem. 2009;52:688\u201399.","journal-title":"J Med Chem"},{"key":"3517_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1524\/ract.2000.88.3-4.229","volume":"88","author":"A Katsifis","year":"2000","unstructured":"Katsifis A, Mattner F, Dikic B, Papazian V. Synthesis of substituted [123I]imidazo[1,2-a]pyridines as potential probes for the study of the peripheral benzodiazepine receptors using SPECT. Radiochim Acta. 2000;88:229\u201332.","journal-title":"Radiochim Acta"},{"key":"3517_CR34","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.1021\/jm991035g","volume":"42","author":"G Trapani","year":"1999","unstructured":"Trapani G, Franco M, Latrofa A, Ricciardi L, Carotti A, Serra M, et al. Novel 2-phenylimidazo[1,2-a]pyridine derivatives as potent and selective ligands for peripheral benzodiazepine receptors: synthesis, binding affinity, and in vivo studies. J Med Chem. 1999;42:3934\u201341.","journal-title":"J Med Chem"},{"key":"3517_CR35","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.2967\/jnumed.109.072223","volume":"51","author":"J Yui","year":"2010","unstructured":"Yui J, Maeda J, Kumata K, Kawamura K, Yanamoto K, Hatori A, et al. 18F-FEAC and 18F-FEDAC: PET of the monkey brain and imaging of translocator protein (18 kDa) in the infarcted rat brain. J Nucl Med. 2010;51:1301\u20139. doi:\n                    10.2967\/jnumed.109.072223\n                    \n                  .","journal-title":"J Nucl Med"},{"key":"3517_CR36","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1111\/ejn.12946","volume":"42","author":"W Saba","year":"2015","unstructured":"Saba W, Goutal S, Kuhnast B, Dolle F, Auvity S, Fontyn Y, et al. Differential influence of propofol and isoflurane anesthesia in a non-human primate on the brain kinetics and binding of [18F]DPA-714, a positron emission tomography imaging marker of glial activation. Eur J Neurosci. 2015;42:1738\u201345. doi:\n                    10.1111\/ejn.12946\n                    \n                  .","journal-title":"Eur J Neurosci"},{"key":"3517_CR37","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/syn.20394","volume":"61","author":"M Imaizumi","year":"2007","unstructured":"Imaizumi M, Briard E, Zoghbi SS, Gourley JP, Hong J, Musachio JL, et al. Kinetic evaluation in nonhuman primates of two new PET ligands for peripheral benzodiazepine receptors in brain. Synapse. 2007;61:595\u2013605. doi:\n                    10.1002\/syn.20394\n                    \n                  .","journal-title":"Synapse"},{"key":"3517_CR38","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.2967\/jnumed.113.135129","volume":"55","author":"A Colasanti","year":"2014","unstructured":"Colasanti A, Guo Q, Muhlert N, Giannetti P, Onega M, Newbould RD, et al. In vivo assessment of brain white matter inflammation in multiple sclerosis with 18F-PBR111 PET. J Nucl Med. 2014;55:1112\u20138. doi:\n                    10.2967\/jnumed.113.135129\n                    \n                  .","journal-title":"J Nucl Med"},{"key":"3517_CR39","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.2967\/jnumed.113.121020","volume":"54","author":"Q Guo","year":"2013","unstructured":"Guo Q, Colasanti A, Owen DR, Onega M, Kamalakaran A, Bennacef I, et al. Quantification of the specific translocator protein signal of 18F-PBR111 in healthy humans: a genetic polymorphism effect on in vivo binding. J Nucl Med. 2013;54:1915\u201323. doi:\n                    10.2967\/jnumed.113.121020\n                    \n                  .","journal-title":"J Nucl Med"},{"key":"3517_CR40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.apradiso.2014.03.009","volume":"90","author":"T Bourdier","year":"2014","unstructured":"Bourdier T, Henderson D, Fookes CJ, Lam P, Mattner F, Fulham M, et al. Synthesis of [11C]PBR170, a novel imidazopyridine, for imaging the translocator protein with PET. Appl Radiat Isot. 2014;90:46\u201352. doi:\n                    10.1016\/j.apradiso.2014.03.009\n                    \n                  .","journal-title":"Appl Radiat Isot"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-016-3517-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-016-3517-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-016-3517-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T09:52:28Z","timestamp":1549619548000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-016-3517-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,4]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["3517"],"URL":"https:\/\/doi.org\/10.1007\/s00259-016-3517-z","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,4]]},"assertion":[{"value":"30 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}